4.4 Article

Plasma glucagon-like peptide-1 responses to ingestion of protein with increasing doses of milk minerals rich in calcium

期刊

BRITISH JOURNAL OF NUTRITION
卷 128, 期 1, 页码 55-63

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S000711452100297X

关键词

Calcium; Protein; GLP-1; Appetite; Energy intake

资金

  1. Arla Foods Ingredients
  2. University of Bath
  3. BBSRC
  4. MRC
  5. British Heart Foundation
  6. Lucozade Ribena Suntory
  7. Arla Foods Ingredient
  8. Kenniscentrum Suiker and Voeding
  9. Rare Disease Foundation
  10. EU Hydration Institute
  11. GlaxoSmithKline
  12. Nestle
  13. ARLA Foods
  14. Kennis Centrum Suiker

向作者/读者索取更多资源

This study aimed to assess the impact of different calcium doses ingested alongside whey protein hydrolysate on GLP-1 concentrations in individuals with overweight/obesity. The results showed that co-ingestion of whey protein hydrolysate with Capolac(R) did not potentiate GLP-1 release compared to whey protein hydrolysate alone.
A high dose of whey protein hydrolysate fed with milk minerals rich in calcium (Capolac(R)) results in enhanced glucagon-like peptide-1 (GLP-1) concentrations in lean individuals; however, the effect of different calcium doses ingested alongside protein is unknown. The present study assessed the dose response of calcium fed alongside 25 g whey protein hydrolysate on GLP-1 concentrations in individuals with overweight/obesity. Eighteen adults (mean +/- sd: 8M/10F, 34 +/- 18 years, 28 center dot 2 +/- 2 center dot 9 kgm(-2)) completed four trials in a randomised, double-blind, crossover design. Participants consumed test solutions consisting of 25 g whey protein hydrolysate (CON), supplemented with 3179 mg (LOW), 6363 mg (MED) or 9547 mg (HIGH) Capolac(R) on different occasions, separated by at least 48 h. The calcium content of test solutions equated to 65, 892, 1719 and 2547 mg, respectively. Arterialised-venous blood was sampled over 180 min to determine plasma concentrations of GLP-1(TOTAL), GLP-1(7-36amide), insulin, glucose, NEFA, and serum concentrations of calcium and albumin. Ad libitum energy intake was measured at 180 min. Time-averaged incremental AUC (iAUC) for GLP-1(TOTAL) (pmol center dot l(-1)center dot min(-1)) did not differ between CON (23 +/- 4), LOW (25 +/- 6), MED (24 +/- 5) and HIGH (24 +/- 6). Energy intake (kcal) did not differ between CON (940 +/- 387), LOW (884 +/- 345), MED (920 +/- 334) and HIGH (973 +/- 390). Co-ingestion of whey protein hydrolysate with Capolac(R) does not potentiate GLP-1 release in comparison with whey protein hydrolysate alone. The study was registered at clinical trials (NCT03819972).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据